MedTrace Logo

Castleman Disease Collaborative Network Biobank

NCT02871050 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-07-31

No results posted yet for this study

Summary

The purpose of this study is to create a biobank, which collects, stores, and distributes samples of human tissues, blood, and related health information to qualified scientists, in order to help doctors and researchers better understand why Castleman Disease occurs and develop ways to better treat and prevent it.

Conditions

  • Castleman Disease
  • Castleman's Disease
  • Giant Lymph Node Hyperplasia
  • Angiofollicular Lymph Hyperplasia
  • Angiofollicular Lymph Node Hyperplasia
  • Angiofollicular Lymphoid Hyperplasia
  • GLNH
  • Hyperplasia
  • Giant Lymph Node

Interventions

OTHER

Sample Collection

Excess blood sample tubes and/or buccal swabs or saliva will have DNA and RNA extracted and serum and plasma separated out to be stored for future research purposes based on the results of this preliminary research.

Sponsors & Collaborators

  • Castleman Disease Collaborative Network

    lead OTHER

Principal Investigators

  • David C Fajgenbaum, MD, MBA, MSc · Executive Director of Castleman Disease Collaborative Network

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02871050 on ClinicalTrials.gov